September 5, 2008 - Boston’s Brigham & Women’s (B&W) Hospital, a 777-bed teaching affiliate of Harvard Medical School ...
Cardiac Science launched its HeartCentrix 6.2 data management product for the physician office to connect Burdick and ...
September 5, 2008 - Digirad Corp. today announced the initial clinical trial of its new SPECT imaging system ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
September 4, 2008 - GE Healthcare's Diagnostic Cardiology Service team prides itself on exceeding the expectations of ...
The process of the coronary CT angiography (CTA) becoming the preferred imaging modality is akin to the process of obtaining a pilot’s license.
LUMEDX Corp. offers the CardioPACS 5.0, the latest version of its cardiology PACS software. The multimodality, Web ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Cook Medical has received approval from the FDA for its Zenith TX2 Thoracic TAA Endovascular Graft, marking the expansion of Cook Medical’s portfolio of devices to treat aortic diseases.
St. Jude Medical Inc. recently released its EnSite System Version 8.0, software designed to intuitively visualize the ...
Nihon Kohden America Inc. said its Prefense Early Detection and Notification System received 510(k) clearance from the ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The use of embolic protection devices (EPD) during percutaneous cardiac procedures has helped reduce the number of complications due to debris being released into the bloodstream and causing blockages in smaller vessels. The devices are designed to capture and remove debris that may be dislodged during procedures. There are three classes of EPD devices:
In as much as the environment in which you live can affect your quality of life, so can the environment in which someone receives medical care affect patient outcome – at least in theory.
The FDA recently cleared Boston Scientific Corp.’s PROMUS Everolimus-Eluting Coronary Stent System and Abbott Vascular’s ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
AngioScore Inc. has introduced longer and larger AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD).
The R Series defibrillator for hospitals aims for simplicity and operational readiness to help improve in-hospital ...
September 3, 2008 – While a recent study into whether using unselected and selected bone-marrow derived cells can help with regeneration of heart tissue did not lead to significant improvement of LVEF and LV volumes in comparison to control group, there was a trend toward significant improvement of LVEF in patients with severely depressed baseline LVEF receiving either MNC or CD34 CXCR4 bone ma
September 04, 2008
